MD20150017A2 - Use of Polybiolin drug in patients with liver cirrhosis - Google Patents
Use of Polybiolin drug in patients with liver cirrhosisInfo
- Publication number
- MD20150017A2 MD20150017A2 MDA20150017A MD20150017A MD20150017A2 MD 20150017 A2 MD20150017 A2 MD 20150017A2 MD A20150017 A MDA20150017 A MD A20150017A MD 20150017 A MD20150017 A MD 20150017A MD 20150017 A2 MD20150017 A2 MD 20150017A2
- Authority
- MD
- Moldova
- Prior art keywords
- drug
- polybiolin
- patients
- liver cirrhosis
- medicine
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to medicine, namely to the use of Polybiolin drug in patients with liver cirrhosis, wherein the drug is administered intramuscularly, 5 ml for 8…10 days.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20150017A MD4458C1 (en) | 2014-06-19 | 2014-06-19 | Use of Polybiolin drug in patients with liver cirrhosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20150017A MD4458C1 (en) | 2014-06-19 | 2014-06-19 | Use of Polybiolin drug in patients with liver cirrhosis |
Publications (3)
Publication Number | Publication Date |
---|---|
MD20150017A2 true MD20150017A2 (en) | 2016-04-30 |
MD4458B1 MD4458B1 (en) | 2017-01-31 |
MD4458C1 MD4458C1 (en) | 2017-08-31 |
Family
ID=55911138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20150017A MD4458C1 (en) | 2014-06-19 | 2014-06-19 | Use of Polybiolin drug in patients with liver cirrhosis |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD4458C1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0827742A1 (en) * | 1996-09-04 | 1998-03-11 | Vrije Universiteit Brussel | Use of histone deacetylase inhibitors for treating fribosis or cirrhosis |
MD1780G2 (en) * | 2001-02-02 | 2002-05-31 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method of treatment of patients with hepatic cirrhosis |
DE102005025906A1 (en) * | 2005-06-06 | 2006-12-07 | Dorian Bevec | Use of a guanylhydrazone compound in the manufacture of medicament for the treatment and/or prevention of e.g. acute and chronic hepatitis, liver cirrhosis, liver cell carcinoma, myocarditis, pharyngitis, pneumonia and pericarditis |
DE102005059750A1 (en) * | 2005-12-09 | 2007-06-14 | Salama, Zoser Boulis, Dr. | Use of tetraorganosilicon compound having cell proliferation inhibitory activity, e.g. as an immunstimulator to treat viral-, bacterial- and/or tumor diseases, anemia, arteriosclerosis, arthritis, asthma, autoimmune disease, and cirrhosis |
FR2952826B1 (en) * | 2009-11-20 | 2012-04-06 | Lab Francais Du Fractionnement | USE OF MULTIPURPOSE IMMUNOGLOBULINS FOR TREATING ALCOHOLIC OR METABOLIC HEPATIC CIRRHOSIS |
MD4317C1 (en) * | 2013-09-12 | 2015-08-31 | Георге АНГЕЛИЧ | Use of 3-(2,2,2-trimethylhydrazinium)propionate dihydrate for treating patients with advanced liver cirrhosis associated with heart failure |
-
2014
- 2014-06-19 MD MDA20150017A patent/MD4458C1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MD4458C1 (en) | 2017-08-31 |
MD4458B1 (en) | 2017-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016501830A1 (en) | Inhibitors of c5a for the treatment of viral pneumonia | |
TN2017000554A1 (en) | Novel combination for use in the treatment of cancer | |
MX370792B (en) | Methods and compositions for the treatment of cancer. | |
PH12016502352A1 (en) | Pharmaceutical composition | |
TW201613578A (en) | Pharmaceutical combinations | |
EA201790726A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ULCERAL COLITIS | |
EA201691918A1 (en) | PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | |
NZ710291A (en) | 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions | |
PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
MX2018006226A (en) | 5-hydroxytryptamine 1b receptor-stimulating agent for enhancing in vivo engraftment potential. | |
PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
MD4763B1 (en) | Pharmaceutical composition | |
PH12017500323A1 (en) | P38 map kinase inhibiting indanyl urea compounds | |
MD20150017A2 (en) | Use of Polybiolin drug in patients with liver cirrhosis | |
MX2016013979A (en) | New administration routes of insulin, insulin analogs or derivatives of insulin. | |
MD4317B1 (en) | Use of 3-(2,2,2-trimethylhydrazinium)propionate dihydrate for treating patients with advanced liver cirrhosis associated with heart failure | |
TR201716203A1 (en) | New umeclidinium formulations. | |
MX2017005669A (en) | Benzylhydroxyde derivatives, preparation thereof and therapeutic use thereof. | |
MD4316C1 (en) | Use of 3-(2,2,2-trimethylhydrazinium)propionate dihydrate for treating portal gastropathies in patients with liver cirrhosis | |
PL414785A1 (en) | 3-dodecylsulfanyl-butyric acid to be used as a medicine, preferably to prevent development of insulin immunity and the composition containing 3-dodecylsulfanyl-butyric acid as active substance | |
BR112017003900A2 (en) | testosterone formulations and treatment methods with them | |
IN2014DE00822A (en) | ||
IN2013MU03838A (en) | ||
MX366763B (en) | PHARMACEUTICAL COMPOSITIONS OF MONTELUKAST and LEVOCETIRIZINE. | |
UA91605U (en) | Method for correcting disordered microcirculation in gastric mucosa of aged patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |